Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | CA12 | O43570 | 3/20 | 0.50 |
| ▸ | CA1 | P00915 | 3/20 | 0.50 |
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | CA7 | P43166 | 3/20 | 0.50 |
| ▸ | CA9 | Q16790 | 3/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.45 |
| ▸ | ESR1 | P03372 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | MGAM | O43451 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | SI | P14410 | 1/20 | 0.44 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29254490 | 0.87 | ALDH1A1 (0.54) | KMT2AALDH1A1MEN1KDM4EHPGD | |
| SCHEMBL30951612 | 0.87 | ALDH1A1 (0.54) | KMT2AALDH1A1MEN1KDM4EHPGD | |
| SCHEMBL9471937 | 0.84 | HSP90AA1 (0.51) | KMT2AALDH1A1MEN1KDM4ECA12 | |
| SCHEMBL25966580 | 0.83 | HSD17B2 (0.68) | KMT2AALDH1A1MEN1KDM4EHSD17B2 | |
| SCHEMBL30081035 | 0.83 | MEN1 (0.50) | KMT2AALDH1A1MEN1KDM4EHPGD | |
| SCHEMBL22257233 | 0.83 | ALDH1A1 (0.50) | KMT2AALDH1A1MEN1KDM4EHPGD | |
| SCHEMBL5773909 | 0.83 | MEN1 (0.50) | KMT2AALDH1A1MEN1KDM4EHPGD | |
| SCHEMBL10568457 | 0.81 | MEN1 (0.64) | KMT2AALDH1A1MEN1KDM4EHSD17B2 | |
| SCHEMBL10459828 | 0.80 | CA12 (0.46) | KMT2AKDM4ECA12CA1CA2 | |
| SCHEMBL17290642 | 0.80 | TAS1R3 (0.50) | KMT2AALDH1A1MEN1KDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240018114-A1 | PREPARATION METHOD FOR CANNFLAVIN COMPOUNDS | DEYI PHARMACEUTICAL LTD. (CN) | 2024-01-18 | — | — | US | disclosed |
| CN-109134444-B | 3- (2-furan) -4-hydroxycoumarin compound, preparation method thereof and application thereof in resisting plant fungi | 陕西师范大学 | 2021-07-23 | — | — | CN | disclosed |
| EP-3006440-B1 | TETRAZOLINONE COMPOUND AND APPLICATION OF SAME | SUMITOMO CHEMICAL CO (JP) | 2018-03-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240018114-A1 | PREPARATION METHOD FOR CANNFLAVIN COMPOUNDS | HSPB1, HMBS, CYP8B1 | KMT2A 817/4885ALDH1A1 882/4885MEN1 1378/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.